Mother Teresa: A saint despite spiritual 'darkness'

August 31, 2016

Vatican City, Aug 31: When Pope Francis canonizes Mother Teresa on Sunday, he'll be honoring a nun who won admirers around the world and a Nobel Peace Prize for her joy-filled dedication to the "poorest of the poor."image

He'll also be recognising holiness in a woman who felt so abandoned by God that she was unable to pray and was convinced, despite her ever-present smile, that she was experiencing the "tortures of hell."

For nearly 50 years, Mother Teresa endured what the church calls a "dark night of the soul" a period of spiritual doubt, despair and loneliness that many of the great mystics experienced, her namesake St. Therese of Lisieux included. In Mother Teresa's case, the dark night lasted most of her adult life, an almost unheard of trial.

No one but Mother Teresa's spiritual directors and bishop knew of her spiritual agony until her correspondence came to light during her beatification cause. The letters were then made available to the general public in a 2007 book, "Come Be My Light."

For the Rev. Brian Kolodiejchuk, the Canadian priest who published the letters and spearheaded Mother Teresa's saint- making campaign, the revelations were further confirmation of Mother Teresa's heroic saintliness. He said that by canonizing her, Francis is recognising that Mother Teresa not only shared the material poverty of the poor but the spiritual poverty of those who feel "unloved, unwanted, uncared for."

"That was her experience in her relationship with Jesus," Kolodiejchuk said in an interview. "She understood very well when people would share their horror stories, their pain and suffering of being unloved, lonely. She would be able to share that empathy because she herself was experiencing it."

Tens of thousands of people are expected for the canonization ceremony Sunday for the tiny, stooped nun who was fast-tracked for sainthood just a year after she died in 1997.

St. John Paul II, who was Mother Teresa's greatest champion, beatified her before a crowd of 300,000 in St. Peter's Square in 2003.

Francis has made the canonization the high point of his Jubilee of Mercy, a yearlong emphasis on the church's merciful side. Francis has an obvious interest in highlighting Mother Teresa's mercy-filled service to outcasts on the periphery, given that her life's work exemplifies the priorities of his own pontificate.

But Francis is also sending a more subtle message to the faithful through the canonization of the ethnic Albanian nun: That saints can be imperfect they can suffer as Mother Teresa did and even feel unloved by God, said Ines Angeli Murzaku, a professor of church history at Seton Hall University in New Jersey and herself a native Albanian.
"That existential periphery which is suffering and being marginalized, he wants to bring that to the attention of the world," she said in a telephone interview. Mother Teresa "is so real. She's not remote. She's not a perfect, perfect saint."

That said, her blind faith in enduring the "darkness," as she called it, and persevering through it seems almost superhuman to outsiders.

Take the Feb. 28, 1957 letter she wrote the then- archbishop of Kolkata, Jesuit Archbishop Ferdinand Perier.

"There is so much contradiction in my soul. Such deep longing for God, so deep that it is painful, a suffering continual, and yet not wanted by God, repulsed, empty, no faith, no love no zeal," she wrote. "Souls hold no attraction. Heaven means nothing, to me it looks like an empty place. The thought of it means nothing to me and yet this torturing longing for God."

"Pray for me please that I keep smiling at him in spite of everything."
In another letter, she acknowledged that her smile was "a big cloak which covers a multitude of pains."

Revelations that the smile was a mask to inner doubts about God's presence fueled criticism of Mother Teresa spearheaded most famously by the late Christopher Hitchens that the Balkan nun was something of a fraud.

Kolodiejchuk, though, says she was no hypocrite. He said that the smile was a genuine and heroic attempt to hide her private sufferings, even from God, and prevent others from suffering more.

"You can be joyful even if you're suffering because you are accepting, and you are working and acting with love that gives meaning to the suffering," he said in the courtyard of one of the Missionaries of Charity houses on the periphery of Rome.

The revelations nevertheless shocked even Mother Teresa's closest confidants and friends, the original sisters who joined her Missionaries of Charity after she was inspired to found the order in 1946. Kolodiejchuk said several sisters wept when he first read them her letters after he acquired them in 1998 from the archives of the Jesuits and archbishop in Kolkata.

Sister Prema, the current superior general of the Missionaries of Charity, recalled being in awe of the revelation and not being able even today to fully understand the depth of Mother Teresa's pain.

Kolodiejchuk, the postulator for the cause, says that in retrospect, Mother Teresa's "darkness" was actually a critical part of her vocation, kept hidden from the world that only saw a firm but loving mother superior who was the first in the chapel each morning and often worked herself to exhaustion at night tending to society's most unloved.

"We assumed at least she was enjoying this wonderful consoling union and love from Jesus," he said. "But we discover, no it's even the opposite. For me, this darkness is the single most heroic aspect of her life."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 28,2020

Los Angeles, Apr 28: People who experience loss of smell as one of the COVID-19 symptoms are likely to have a mild to moderate clinical course of the disease, according to a study which may help health care providers determine which patients require hospitalisation.

The findings, published in the journal International Forum of Allergy & Rhinology, follows an earlier study that validated the loss of smell and taste as indicators of infection with the novel coronavirus, SARS-CoV-2.

According to the scientists from the University of California (UC) San Diego Health in the US, patients who reported loss of smell were 10 times less likely to be hospitalised for COVID-19 compared to those without the symptom.

"One of the immediate challenges for health care providers is to determine how to best treat persons infected by the novel coronavirus," said Carol Yan, first author of the current study and rhinologist from the UC San Diego Health.

"If they display no or mild symptoms, can they return home to self-quarantine or will they likely require hospitalisation? These are crucial questions for hospitals trying to efficiently and effectively allocate finite medical resources," Yan said.

The findings, according to the researchers, suggest that loss of smell may be predictive of a milder clinical course of COVID-19.

"What's notable in the new findings is that it appears that loss of smell may be a predictor that a SARS-CoV-2 infection will not be as severe, and less likely to require hospitalisation," Yan said.

"If an infected person loses that sense, it seems more likely they will experience milder symptoms, barring other underlying risk factors," she added.

Risk factors for COVID-19 previously reported by other studies include age, and underlying medical conditions, such as chronic lung disease, serious heart conditions, diabetes, and obesity.

In the current study, the scientists made a retrospective analysis between March 3 and April 8 including 169 patients who tested positive for COVID-19 at UC San Diego Health.

They assessed olfactory and gustatory data for 128 of the 169 patients, 26 of whom required hospitalisation.

According to the researchers, patients who were hospitalised for COVID-19 treatment were significantly less likely to report anosmia or loss of smell -- 26.9 per cent compared to 66.7 per cent for COVID-19-infected persons treated as outpatients.

Similar percentages were found for loss of taste, known as dysgeusia, they said.

"Patients who reported loss of smell were 10 times less likely to be admitted for COVID-19 compared to those without loss of smell," said study co-author Adam S. DeConde.

"Moreover, anosmia was not associated with any other measures typically related to the decision to admit, suggesting that it's truly an independent factor and may serve as a marker for milder manifestations of Covid-19," DeConde said.

The researchers suspect that the findings hint at some of the physiological characteristics of the infection.

"The site and dosage of the initial viral burden, along with the effectiveness of the host immune response, are all potentially important variables in determining the spread of the virus within a person and, ultimately, the clinical course of the infection," DeConde said.

If the SARS-CoV-2 virus initially concentrates in the nose and upper airway, where it impacts olfactory function, that may result in an infection that is less severe and sudden in onset, decreasing the risk of overwhelming the host immune response, respiratory failure, and hospitalisation, the scientists added.

"This is a hypothesis, but it's also similar to the concept underlying live vaccinations," DeConde explained.

"At low dosage and at a distant site of inoculation, the host can generate an immune response without severe infection," he added.

Loss of smell, according to the study, might also indicate a robust immune response which has been localised to the nasal passages, limiting effects elsewhere in the body.

Citing the limitations of the study, the scientists said they relied upon self-reporting of anosmia from participants, which posed a greater chance of recall bias among patients once they had been diagnosed with COVID-19.

They added that patients with more severe respiratory disease requiring hospitalisation may not be as likely to recognise or recall the loss of smell.

So the researchers said more expansive studies are needed for validating the results.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 7,2020

Toronto, May 7: Scientists have uncovered how bats can carry the MERS coronavirus without getting sick, shedding light on what triggers coronaviruses, including the one behind the COVID-19 pandemic, to jump to humans.

According to the study, published in the journal Scientific Reports, coronaviruses like the Middle East respiratory syndrome (MERS) virus, and the COVID19-causing SARS-CoV-2 virus, are thought to have originated in bats.

While these viruses can cause serious, and often fatal disease in people, bats seem unharmed, the researchers, including those from the University of Saskatchewan (USask) in Canada, said.

"The bats don't get rid of the virus and yet don't get sick. We wanted to understand why the MERS virus doesn't shut down the bat immune responses as it does in humans," said USask microbiologist Vikram Misra.

In the study, the scientists demonstrated that cells from an insect-eating brown bat can be persistently infected with MERS coronavirus for months, due to important adaptations from both the bat and the virus working together.

"Instead of killing bat cells as the virus does with human cells, the MERS coronavirus enters a long-term relationship with the host, maintained by the bat's unique 'super' immune system," said Misra, one of the study's co-authors.

"SARS-CoV-2 is thought to operate in the same way," he added.

Stresses on bats, such as wet markets, other diseases, and habitat loss, may have a role in coronavirus spilling over to other species, the study noted.

"When a bat experiences stress to their immune system, it disrupts this immune system-virus balance and allows the virus to multiply," Misra said.

The scientists, involved in the study, had earlier developed a potential treatment for MERS-CoV, and are currently working towards a vaccine against COVID-19.

While camels are the known intermediate hosts of MERS-CoV, they said bats are suspected to be the ancestral host.

There is no vaccine for either SARS-CoV-2 or MERS, the researchers noted.

Follow latest updates on the COVID-19 pandemic here

"We see that the MERS coronavirus can very quickly adapt itself to a particular niche, and although we do not completely understand what is going on, this demonstrates how coronaviruses are able to jump from species to species so effortlessly," said USask scientist Darryl Falzarano, who co-led the study.

According to Misra, coronaviruses rapidly adapt to the species they infect, but little is known on the molecular interactions of these viruses with their natural bat hosts.

An earlier study had shown that bat coronaviruses can persist in their natural bat host for at least four months of hibernation.

When exposed to the MERS virus, the researchers said, bat cells adapt, not by producing inflammation-causing proteins that are hallmarks of getting sick, but instead by maintaining a natural antiviral response.

On the contrary, they said this function shuts down in other species, including humans.

The MERS virus, the researchers said, also adapts to the bat host cells by very rapidly mutating one specific gene.

These adaptations, according to the study, result in the virus remaining long-term in the bat, but being rendered harmless until something like a disease, or other stressors, upsets this balance.

In future experiments, the scientists hope to understand how the bat-borne MERS virus adapts to infection and replication in human cells.

"This information may be critical for predicting the next bat virus that will cause a pandemic," Misra said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 27,2020

Mumbai, Jan 27: The country's largest car maker Maruti Suzuki India (MSI) on Monday said it has increased prices of select models by up to Rs 10,000 with immediate effect to offset the impact of rising input costs.

The price change varies across models and ranges up to 4.7 per cent (ex-showroom Delhi) and are effective from January, 27 2020, MSI said in a statement.

The price of entry level model Alto range has gone up in the range of Rs 9,000-6,000, S-Presso between Rs 1,500 to 8,000, WagonR between Rs 1,500 and Rs 4,000.

The company has also increased the price of its multi purpose vehicle Ertiga between Rs 4,000-10,000, Baleno by Rs 3,000 to 8,000 and XL6 by up to Rs 5,000 (all prices ex-showroom Delhi).

Currently, the company sells a range of vehicles starting from entry-level small car Alto to premium multi purpose vehicle XL6 with price ranging from Rs 2.89 lakh to Rs 11.47 lakh (ex-showroom Delhi).

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.